Lysophosphatidic acid in vascular development and disease
about
G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT SignalingInternational Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters.Group VIA phospholipase A2 in both host and tumor cells is involved in ovarian cancer development.Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vesselsLysophosphatidic acid signalling in developmentLysophosphatidic Acid signaling in the nervous system.Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.Lysophosphatidic acid-induced p21Waf1 expression mediates the cytostatic response of breast and ovarian cancer cells to TGFβ.Primary human endothelial cells secrete agents that reduce responsiveness to lysophosphatidic acid (LPA).Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.Simple enrichment and analysis of plasma lysophosphatidic acids.Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosisCompartmentalizing the embryo: lipids and septate junction mediated barrier function.Blood-based metabolic signatures in Alzheimer's disease.Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.Expression of autotaxin and lysophosphatidic acid receptors 1 and 3 in the developing rat lung and in response to hyperoxia.Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
P2860
Q26767279-6875CAF0-1667-4877-9E3C-20E57B3DFCC1Q30429523-1506B06D-2C14-4E17-A688-9AD6313BCEA4Q33825153-498315CB-4FCF-43E1-B679-3749264E00C4Q33922964-84BBECEE-58A8-4CF6-B8FC-3A5F2F9F363BQ34378792-3F674487-C46A-4915-A3F4-E72F1BE87E75Q35172962-285CBE3C-2CDC-4054-A76E-999243F19BFCQ35355940-267C0D2E-6ACD-4D53-97BD-6D8CE9313625Q35456340-152D1966-559D-4768-9D63-EA8BF3E53765Q35907288-FD697257-8677-4505-9124-BCB1777A6C9BQ36073708-74B5714C-0FF4-4815-BB71-39E9049A776EQ36083085-5CF4E107-9BD2-43DD-AC18-7EDAA13244C2Q36405959-0770499C-0513-4E2E-B420-C94A29CDFAA7Q37593579-B51351F7-DE0C-4444-B6DD-2E3CBE94BC23Q37712729-17F92DDE-9BDE-455B-81EA-466D3EBC72EDQ40915992-4C994D50-84C8-418E-AF90-87E39B4FC722Q41687826-ED046501-6995-4C6B-854A-B403F5C1D7BEQ46441367-2A48858A-1815-4AB9-8580-DC206CD66354Q50577618-42162E85-678C-4567-9419-B153D24FCF86Q57073812-FA9D8E7D-5935-427B-B16A-C2C00D6C68E3
P2860
Lysophosphatidic acid in vascular development and disease
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lysophosphatidic acid in vascular development and disease
@ast
Lysophosphatidic acid in vascular development and disease
@en
type
label
Lysophosphatidic acid in vascular development and disease
@ast
Lysophosphatidic acid in vascular development and disease
@en
prefLabel
Lysophosphatidic acid in vascular development and disease
@ast
Lysophosphatidic acid in vascular development and disease
@en
P2093
P2860
P356
P1433
P1476
Lysophosphatidic acid in vascular development and disease
@en
P2093
Jerold Chun
Siew T Teo
Yun C Yung
P2860
P304
P356
10.1002/IUB.220
P50
P577
2009-08-01T00:00:00Z